Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03553732 · ClinicalTrials.gov registry record
An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 48
- Enrollment target
NCT03553732: Clinical Trial study, sponsored by University of California, San Francisco.
NCT03553732 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03553732 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 48 participants
- Enrollment target
Study Summary
To implement and evaluate a health information technology platform designed to support the management of patients on active surveillance for prostate cancer in an urban, publicly-funded outpatient setting.
Primary Outcome
measured from date monitoring (e.g. prostate-specific antigen test or biopsy) is scheduled to date monitoring occurs.
Interventions
- OTHER Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2019-09-29 |
Why NCT03553732 stopped before completion
NCT03553732 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Registry is the first listed.
NCT03553732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03553732 about?
NCT03553732 is a clinical study titled "An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital". To implement and evaluate a health information technology platform designed to support the management of patients on active surveillance for prostate cancer in an urban, publicly-funded outpatient setting.
What is the current status of trial NCT03553732?
This trial is currently terminated. The enrollment target is 48 participants. The study started on 2018-07-01. Estimated completion is 2019-09-29.
What interventions are being tested in trial NCT03553732?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT03553732?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI